Investigator-Initiated Clinical Trials
Cancer Research Society
UM Funding ID
FD04291
Sponsor
Cancer Research Society
Category
Canadian Funding Opportunities
Description
This national program aims to:
- Advance new treatment options, particularly for rare, underserved and low survival cancers
- Evaluate innovative approaches to deliver more precise and effective care
- Improve patient outcomes and quality of life, including reducing treatment-related side effects
- Enhance early detection and diagnosis, enabling more timely interventions
- Strengthen prevention strategies aimed at reducing cancer incidence
Two funding streams available:
- Proof of Concept Trials $500,000 over 3 years.
- Full Clinical Trials $2M over 5 years.
VPRI Contact
Michelina Violi
Research Grants Specialist (Health & International)Michelina [dot] .Violi [at] @umanitoba [dot] .ca
Deadlines
| UM Internal Deadline (to ADR) | Sponsor Deadline | |
|---|---|---|
Letter of Intent |
| 04-Jun-2026 |
Application (Upon Invitation Only) | 26-Aug-2026 | 16-Sep-2026 |
Important
The information in this directory is provided as a service to the University Community and anyone with legitimate business with the University. Use of this directory to prepare mass mailings is prohibited.